Key takeaway
Among 29 young adults aged 19-39 using the ANZEILAX-Green app with a smartwatch for 8 weeks, GAD-7 anxiety scores fell by a mean 4.79 points (95% CI -6.56 to -3.02; P<.001). There was no control group, so the drop could reflect expectations, time or other factors rather than the app.
Study design
Research article
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
Many young adults have anxiety but cannot get timely treatment. Digital tools that ask about mood in the moment (ecological momentary assessment and intervention, EMA/EMI) could help, and wearable data might make the feedback more personal. The authors tested the real-world feasibility and effect of ANZEILAX-Green, which combines EMA/EMI with smartwatch data on heart rate, sleep and activity.
Who and how
Eight-week exploratory mixed-methods experimental study of young adults aged 19-39, with 29 in the final analysis. Participants used a smartphone app with EMA/EMI modules linked to a smartwatch that continuously collected heart rate, sleep and activity. The Generalized Anxiety Disorder 7-item scale (GAD-7) and Patient Health Questionnaire-9 (PHQ-9) were measured at baseline and weeks 2, 4, 6 and 8, and the Rosenberg Self-Esteem Scale (RSES) at baseline and week 8. Changes were tested with paired t tests and repeated-measures ANOVA, and interviews were analyzed thematically.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1GAD-7 fell by a mean 4.79 points (95% CI -6.56 to -3.02; Cohen d=1.03; P<.001); PHQ-9 fell by 3.86 (-5.79 to -1.93; d=0.76; P<.001); RSES rose by 5.21 (3.47 to 6.95; d=1.14; P<.001).
- 2GAD-7 improved consistently across assessments, with statistically significant reductions from week 4 onward.
- 3Adherence was high: participants completed 80% of EMA/EMI prompts.
- 4The wearable data showed trends toward more deep sleep and less mobility, and sleep indicators were significantly correlated with depressive symptoms. Interviews described 5 mechanisms: enhanced self-awareness, data-driven reflection, behavioral change, intrinsic motivation and extension of treatment into daily life.
Limits & uncertainty
- 1No control group, so the within-group improvements cannot be credited to the app or the wearable data.
- 2Only 29 participants analyzed, an exploratory design, and the abstract does not say how many started or whether they had diagnosed anxiety.
- 3Anxiety and depression were self-reported on questionnaires, and participants knew they were being treated.
- 4The authors say the effect needs confirmation in a controlled trial. This reading is based on the abstract only.
What to take from it
A mood check-in app paired with a smartwatch was well used and acceptable to these young adults, and their anxiety scores fell, but this cannot show the app was the cause. Persistent anxiety is a matter for a clinician or mental health professional, not an app alone.
Reading your own data
The smartwatch recorded heart rate, sleep and activity, and deep sleep and mobility moved over the 8 weeks. If you log mood alongside sleep and activity, use the same device and look at weekly patterns instead of single nights, and treat the link between sleep and mood as a pattern to discuss, not a diagnosis.
How to read this evidence
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
Young adults report high levels of anxiety, yet their access to timely treatment remains limited. Mobile-based digital therapeutics, particularly ecological momentary assessment and intervention (EMA/EMI), offer a promising approach to deliver context-responsive care. The integration of wearable-derived digital phenotypes with digital therapeutics may enhance the personalization of feedback in such interventions, but empirical evidence from real-world settings remains scarce.
Objective
This study examined the real-world applicability and effectiveness of an EMA/EMI-based digital therapeutic, ANZEILAX-Green (HAII Corp), for use in anxiety reduction in young adults and investigated how personalized feedback generated by combining EMA/EMI data with wearable-based digital phenotypes ameliorates symptoms and promotes self-management and user engagement.
Methods
An 8-week exploratory experimental study was conducted with young adults aged 19-39 years. Participants used a smartphone app in which EMA/EMI modules had been integrated with a smartwatch that continuously collected digital phenotyping data, including heart rate, sleep, and activity. Psychological outcomes were assessed using the Generalized Anxiety Disorder 7-item scale (GAD-7) and Patient Health Questionnaire-9 (PHQ-9) at baseline and weeks 2, 4, 6, and 8, and the Rosenberg Self-Esteem Scale (RSES) at baseline and week 8. Quantitative changes were analyzed using paired-samples t tests and repeated-measures ANOVA, and qualitative interviews were thematically analyzed to identify user experience mechanisms and design implications.
Results
In all, 29 participants were included in the final analysis. Significant improvements were observed in their GAD-7 (mean difference -4.79, 95% CI -6.56 to -3.02; Cohen d=1.03; P<.001), PHQ-9 (mean difference -3.86, 95% CI -5.79 to -1.93; Cohen d=0.76; P<.001), and RSES scores (mean difference +5.21, 95% CI 3.47 to 6.95; Cohen d=1.14; P<.001). Consistent improvements in GAD-7 scores were observed across the assessment points, with statistically significant reductions from week 4 onward. Participants demonstrated high adherence, completing 80% of the EMA/EMI prompts. The digital phenotype showed trends of increased deep sleep and reduced mobility, and sleep indicators were significantly correlated with depressive symptoms. Analysis of the interview findings revealed 5 mechanisms: enhanced self-awareness, data-driven reflection, behavioral change, intrinsic motivation, and extension of treatment into daily life.
Conclusions
EMA/EMI-based digital therapeutics integrated with wearable-derived digital phenotypes are feasible and acceptable for use by young adults and were associated with within-group reductions in anxiety, suggesting acceptable efficacy, though this warrants confirmation in a controlled trial. The combination of real-time self-reported assessments of emotional states and passive physiological monitoring enables personalized feedback suited to users' emotional and physiological states. These findings offer empirical and design insights for automated, personalized mental health intervention systems.
Sources & attribution
Integration of Ecological Momentary Assessment and Intervention With Wearable-Based Digital Phenotypes to Treat Anxiety in Young Adults: Mixed Methods Experimental Study.
Song H, Choi Y, Park J, Hwang H, Kim J, Park C.
JMIR mHealth and uHealth · 2026-10-08
DOI: 10.2196/88919 ↗PubMed · 42849895 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
Activity–stroke and heart attack curves differ by accelerometer processing method
Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.
Preventive Medicine
Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven
A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.
Forensic Science International
Activity trackers: about 1,800 more steps a day, but small effects on other outcomes
An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.
The Lancet Digital Health
Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages
In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.
Sleep

